Why the study?
Does ranolazine maintain sinus rhythm in a patient with refractory symptomatic atrial fibrillation?
Does ranolazine maintain sinus rhythm in a patient with refractory symptomatic atrial fibrillation?
Ranolazine may offer a potential off-label treatment option for maintaining sinus rhythm in highly refractory symptomatic atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Ranolazine merits further study in refractory AF; this case report leaves open its efficacy and should not alter practice.
We report on a patient who was treated with several antiarrhythmic drugs as well as different ablation strategies. Nevertheless, symptomatic atrial fibrillation always recurred until an off-label use with ranolazine was started. We could demonstrate potent effects of ranolazine on atrial fibrillation in a "wash-in wash-out" situation. Although promising controlled studies are needed to investigate a potential role of ranolazine for the treatment of atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Sossalla et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: